TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
XNCR

Xencor Inc

Healthcare · Biotechnology

23.80$ -0.3% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement XNCR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
194.5% 123.0% 59.3% 201.0% 240.1% 75.7% 138.4% 2.7% 5.3% 150.6% 206.1% 8.4%
-94.5% 100.0% 100.0% 100.0% 100.0% 24.3% 100.0% 100.0% 100.0% -50.6% -106.1% 91.6%
194.5% 123.0% 59.3% 201.0% 240.1% 75.7% 138.4% 70.0% 121.3% 150.6% 206.1% 190.7%
78.4% 43.1% 15.0% 49.0% 55.3% 15.5% 24.2% 14.1% 28.9% 31.7% 45.3% 50.7%
272.9% 166.1% 74.2% 250.0% 295.5% 15.5% 162.6% 84.1% 150.1% 182.4% 55.4% 233.0%
-172.9% -66.1% 25.8% -150.0% -195.5% 8.8% -62.6% 15.9% -50.1% -82.4% -161.5% -141.4%
0.1% 0.0% 0.0% 0.0% 0.0% 11.3% 0.0% 2.7% 22.3% 3.7% 33.2% 25.4%
-172.5% -63.4% 28.1% -138.3% -173.4% 17.3% -56.5% 30.0% -33.1% -71.5% -212.6% -71.2%
-8.7% -4.0% 1.1% -1.3% 22.1% 0.2% -4.7% -2.7% 0.4% 3.5% 1.5% 2.0%
-172.5% -63.4% 27.0% -137.0% -173.4% 17.2% -51.8% 30.0% -33.5% -74.9% -210.5% -73.2%
-163.1% -62.0% 27.4% -144.3% -187.5% 11.6% -57.9% 18.6% -44.8% -74.8% -168.5% -37.4%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?